ATE269121T1 - Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels - Google Patents

Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels

Info

Publication number
ATE269121T1
ATE269121T1 AT97922497T AT97922497T ATE269121T1 AT E269121 T1 ATE269121 T1 AT E269121T1 AT 97922497 T AT97922497 T AT 97922497T AT 97922497 T AT97922497 T AT 97922497T AT E269121 T1 ATE269121 T1 AT E269121T1
Authority
AT
Austria
Prior art keywords
dimethylsulfoxyde
kit
agent containing
glass vials
vascular embolization
Prior art date
Application number
AT97922497T
Other languages
English (en)
Inventor
Michael L Jones
Richard J Greff
Original Assignee
Micro Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/688,050 external-priority patent/US5695480A/en
Priority claimed from US08/730,701 external-priority patent/US5830178A/en
Application filed by Micro Therapeutics Inc filed Critical Micro Therapeutics Inc
Application granted granted Critical
Publication of ATE269121T1 publication Critical patent/ATE269121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT97922497T 1996-07-29 1997-04-25 Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels ATE269121T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/688,050 US5695480A (en) 1996-07-29 1996-07-29 Embolizing compositions
US08/730,701 US5830178A (en) 1996-10-11 1996-10-11 Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
PCT/US1997/007047 WO1998004312A1 (en) 1996-07-29 1997-04-25 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide

Publications (1)

Publication Number Publication Date
ATE269121T1 true ATE269121T1 (de) 2004-07-15

Family

ID=27104149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922497T ATE269121T1 (de) 1996-07-29 1997-04-25 Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels

Country Status (7)

Country Link
EP (1) EP0923399B1 (de)
JP (1) JP4717164B2 (de)
AT (1) ATE269121T1 (de)
AU (1) AU2814697A (de)
CA (1) CA2260047A1 (de)
DE (1) DE69729569T2 (de)
WO (1) WO1998004312A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015541A (en) 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6303100B1 (en) * 1999-03-19 2001-10-16 Micro Therapeutics, Inc. Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms
US6645167B1 (en) 1999-05-21 2003-11-11 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an embolizing composition
US7018365B2 (en) 1999-05-21 2006-03-28 Micro Therapeutics, Inc. Threaded syringe with quick stop
WO2000071064A1 (en) * 1999-05-21 2000-11-30 Micro Therapeutics, Inc. Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity
EP1263803B1 (de) 2000-03-13 2007-09-19 BioCure, Inc. Embolische zusammensetzungen
US6981245B1 (en) 2000-09-14 2005-12-27 Sun Microsystems, Inc. Populating binary compatible resource-constrained devices with content verified using API definitions
US7462366B2 (en) * 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7459142B2 (en) * 2002-06-06 2008-12-02 Micro Therapeutics, Inc. High viscosity embolizing compositions comprising prepolymers
ATE429940T1 (de) * 2003-03-07 2009-05-15 Micro Therapeutics Inc Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen
NO20052428D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Kontrastmidler
CA2852386C (en) * 2011-10-17 2019-05-21 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
JP6383133B1 (ja) * 2018-02-21 2018-08-29 国立大学法人信州大学 液体塞栓剤組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2736339B2 (ja) * 1992-09-30 1998-04-02 株式会社日本感光色素研究所 動脈瘤の液体塞栓材料
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
ES2232711T3 (es) * 1995-07-27 2005-06-01 Micro Therapeutics, Inc. Composiciones de embolizacion.

Also Published As

Publication number Publication date
EP0923399A1 (de) 1999-06-23
AU2814697A (en) 1998-02-20
JP4717164B2 (ja) 2011-07-06
EP0923399B1 (de) 2004-06-16
DE69729569T2 (de) 2005-06-23
DE69729569D1 (de) 2004-07-22
WO1998004312A1 (en) 1998-02-05
CA2260047A1 (en) 1998-02-05
JP2000517298A (ja) 2000-12-26

Similar Documents

Publication Publication Date Title
ATE269121T1 (de) Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels
Carless et al. Fibrin sealant use for minimising peri‐operative allogeneic blood transfusion
ATE210467T1 (de) Celluloseazetat-zusammensetzungen zur verwendung bei der embolisierung von blutgefässen
Fluck et al. Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels
US20060115457A1 (en) Biocompatible hydrogel compositions
WO2002000272A3 (en) Composition and method for the repair and regeneration of cartilage and other tissues
Matsumoto et al. Basic fibroblast growth factor released from a platinum coil with a polyvinyl alcohol core enhances cellular proliferation and vascular wall thickness: an in vitro and in vivo study
CA2326504A1 (en) Flow arrest, double balloon technique for occluding aneurysms or blood vessels
DE69620886D1 (de) Zubereitungen zur embolisierung von blutgefässen
Galla et al. Fibrin/Schwann cell matrix in poly-epsilon-caprolactone conduits enhances guided nerve regeneration
ATE256437T1 (de) Verfahren zur behandlung von harninkontinenz von säugetieren
DE69633195D1 (de) Injektierbare oder implantierbare biomaterialien zum füllen oder abdecken von hohlräumen und lumen eines körpers
EP0847240A4 (de) Embolisierende zusammensetzungen
Richling Homologous controlled-viscosity fibrin for endovascular embolization
CA1116088A (en) Injectable embolization and occlusion solution
US5977252A (en) Covalent modification of surfaces with polymers to increase biocompatibility
WO1997032617A9 (en) Covalent modification of surfaces with polymers to increase biocompatibility
Korompilias et al. Antithrombotic potencies of enoxaparin in microvascular surgery: influence of dose and administration methods on patency rate of crushed arterial anastomoses
JP2001137327A (ja) 液体状創傷被覆材
CN118480258A (zh) 一种温和快速溶解的水凝胶及使用方法
EP0481160A1 (de) Antithrombogene Mischung und Verfahren zu ihrer Herstellung
Aupperle et al. Xenogenic Esophagus Scaffolds Fixed with Several Agents: ComparativeIn VivoStudy of Rejection and Inflammation
Ceible et al. Covalent modification of surfaces with polymers to increase biocompatibility
MXPA98007186A (en) Modification of covalent surfaces with polymers, to increase your bio-compatibili
IT1291444B1 (it) Composti n-solfatati dell'acido ialuronico e dei suoi derivati ad attivita' anticoagulante e non-trombogenica e processo per la loro

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties